Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
Title | Radionetics |
Description | The power to stop cancer. The experience to know how. The dedication to make a The power to stop cancer. The experience to know how. The dedication to make a |
Keywords | N/A |
WebSite | radionetics.com |
Host IP | 75.2.60.5 |
Location | United States |
Site | Rank |
US$1,274
Last updated: 2023-05-19 22:19:14
radionetics.com has Semrush global rank of 0. radionetics.com has an estimated worth of US$ 1,274, based on its estimated Ads revenue. radionetics.com receives approximately 147 unique visitors each day. Its web server is located in United States, with IP address 75.2.60.5. According to SiteAdvisor, radionetics.com is safe to visit. |
Purchase/Sale Value | US$1,274 |
Daily Ads Revenue | US$1 |
Monthly Ads Revenue | US$35 |
Yearly Ads Revenue | US$423 |
Daily Unique Visitors | 9 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
radionetics.com. | A | 600 | IP: 75.2.60.5 |
radionetics.com. | NS | 3600 | NS Record: ns71.domaincontrol.com. |
radionetics.com. | NS | 3600 | NS Record: ns72.domaincontrol.com. |
radionetics.com. | MX | 1800 | MX Record: 0 radionetics-com.mail.protection.outlook.com. |
radionetics.com. | TXT | 3600 | TXT Record: v=spf1 include:spf.protection.outlook.com -all |
radionetics.com. | TXT | 3600 | TXT Record: google-site-verification=RXO-V1CHyKctzYdDS7VQULjFqigG2OFkzMCRqqg6x_0 |
radionetics.com. | TXT | 3600 | TXT Record: 24D8A24CA7 |
toggle menu Menu The power to stop cancer. The experience to know how. The dedication to make a difference. more Careers See our open positions News Radionetics Oncology Appoints Istvan Molnar, M.D. as Chief Medical Officer Our purpose We are bringing the power of precision radiopharmaceuticals into a new era. Radiopharmaceuticals – a class of precision oncology medicines – are poised to transform the treatment of solid tumors. By hitching a radioisotope to a small molecule, these potent therapies can selectively deliver the proven power of radiation directly to tumors throughout the body. We are applying our deep drug discovery and development expertise against novel cancer targets from a broad class of surface receptors to produce targeted small molecule radiopharmaceuticals. We seek to create effective new treatments for cancer patients that enable us to go far beyond what’s been done before – bringing us closer to the day we can say “cure.” Innovative approach, immense |
HTTP/1.1 301 Moved Permanently Location: https://radionetics.com/ Server: Netlify X-Nf-Request-Id: 01GKEDS96MPXHRDYXDSZXYSGYF Date: Sun, 04 Dec 2022 11:19:18 GMT HTTP/2 200 age: 120206 cache-control: public, max-age=0, must-revalidate content-type: text/html; charset=UTF-8 date: Sat, 03 Dec 2022 01:55:52 GMT etag: "535f73088a19ba31470caa0343dbfd79-ssl" server: Netlify strict-transport-security: max-age=31536000 x-nf-request-id: 01GKEDS9C46G70V0YBPX5SP3D5 content-length: 153933 |
Domain Name: RADIONETICS.COM Registry Domain ID: 2637205344_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2022-10-08T09:49:55Z Creation Date: 2021-08-28T19:47:19Z Registry Expiry Date: 2023-08-28T19:47:19Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS71.DOMAINCONTROL.COM Name Server: NS72.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2022-12-04T11:59:25Z <<< |